SchistosomiasisNCT07482215
Prevalence and Molecular Identification of Human Schistosomiasis
An observational study of Schistosomiasis, run by Assiut University.
Trial summary
Schistosomiasis remains one of the most important parasitic diseases of public health concern, particularly in developing countries including Egypt. It is caused by a trematode worm (blood flukes) of the genus Schistosoma Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Schistosomiasis
- What is being tested?
- Molecular phylogenetic and haplotype analysis
- How many people
- 359 participants
- Where
- No sites listed yet
- Study dates
- May 2026to Dec 2027
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Child, Adult, Older adult
Study population: All participants presented in Assiut Governorate hospitals
Who may be able to join
- Patients aged ≥ 5 years of both sexes attending Assiut Governorate hospitals during the study period.
- Patients clinically suspected of having schistosomiasis (urinary and/or intestinal) or referred for parasitological examination.
- Individuals (or guardians, in case of minors) who provide written informed consent.
- Patients willing to provide the required biological samples (urine and/or stool).
Who cannot join
- Patients Received praziquantel within the last 3 months before sample collection
- Patients with incomplete clinical or epidemiological data.
- Patients refusing participation or sample collection.
- Improperly collected, contaminated, or insufficient samples.
- Patients suffering from severe comorbid conditions that may interfere with the interpretation of results (e.g., advanced hepatic or renal failure).
- children with congenital urinary or intestinal anomalies.
About this study
Official title: Prevalence and Molecular Identification of Human Schistosomiasis With Assessment of Associated Epidemiological Risk Factors in Assiut Governorate, Egypt
Schistosomiasis remains one of the most important parasitic diseases of public health concern, particularly in developing countries including Egypt. It is caused by a trematode worm (blood flukes) of the genus Schistosoma
Read the detailed description
Schistosomiasis has been diagnosed in Egypt since pharaonic times (3200 B.C.) by recovering Schistosome eggs and antigens in ancient mummies.In Egypt, Schistosoma mansoni and Schistosoma haematobium have historically been highly endemic, with widespread distribution along the Nile Delta and Valley.(4) Schistosoma haematobium is responsible for urogenital schistosomiasis, with hematuria as its primary manifestation, while Schistosoma mansoni, the prevalent species in Egypt, is causing intestinal schistosomiasis with liver-related sequelae
- Conditions
- Schistosomiasis
- Being tested
- Molecular phylogenetic and haplotype analysis
- Medical subject headings
- Schistosomiasis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Molecular phylogenetic and haplotype analysisDiagnostic test
DNA Sequencing and cox1 Gene Analysis of Schistosoma Isolates
| Study group | Role | What they receive |
|---|---|---|
| Schistosoma haematobium | Urine filtration technique (10 ml urine) for diagnosis Receives: Diagnostic Test: Molecular phylogenetic and haplotype analysis | |
| Schistosoma mansoni | Direct wet mount and Kato-Katz thick smear technique (stool) for diagnosis Receives: Diagnostic Test: Molecular phylogenetic and haplotype analysis |
What is being measured
The primary outcome is the main question the study is designed to answer.
prevalence of human schistosomiasis in the study participants
using conventional microscopic examination
Measured: 24 hours
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Mar 2026
- Study startMay 2026 (estimated)
- Primary completionAug 2027 (estimated)
- Study completionDec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for SchistosomiasisStudies of the same condition, open and under way.
- More trials run by Assiut UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 359 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assiut University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Intesar Heshmat Yousef, Assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07482215
- Sponsor's protocol ID
- PMHS
- Status last verified
- Mar 2026
- First submitted
- 16 Mar 2026
- Last updated
- 19 Mar 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No